Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Syros Pharmaceuticals, Inc. (SYRS) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/18/2019 GN GBT Secures $150 Million Non-Dilutive Term Loan Financing
12/18/2019 GN GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia
10/23/2018 GN Market Trends Toward New Normal in Syros Pharmaceuticals, Westlake Chemical Partners LP, SITO Mobile, ShotSpotter, Motorcar Parts of America, and Benefitfocus — Emerging Consolidated Expectations, Analyst Ratings
05/21/2018 GN Report: Exploring Fundamental Drivers Behind Syros Pharmaceuticals, J & J Snack Foods, Wright Medical Group N.V, HCI Group, Tennant, and Ebix — New Horizons, Emerging Trends, and Upcoming Developments
05/10/2018 BW Syros Reports First Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
05/03/2018 BW Syros to Report First Quarter 2018 Financial Results on Thursday, May 10, 2018
03/26/2018 GN Report: Developing Opportunities within AllianceBernstein Holding, Deutsche Bank Aktiengesellschaft, Syros Pharmaceuticals, Ply Gem, Ensco plc, and Berkshire Hills — Future Expectations, Projections Moving into 2018
03/12/2018 BW Syros Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Accomplishments and Anticipated Milestones
03/05/2018 BW Syros to Present at Upcoming Investor Conferences
01/24/2018 GN New Research Coverage Highlights Oracle, General Dynamics, Agile Therapeutics, Fidelity Southern, Syros Pharmaceuticals, and MSA Safety Incorporated — Consolidated Revenues, Company Growth, and Expectations for 2018
01/04/2018 BW Syros to Present at 36th Annual J.P. Morgan Healthcare Conference
12/10/2017 BW Syros Announces Initial Clinical Data from Ongoing Phase 2 Trial of SY-1425 Showing Biological and Clinical Activity as Single Agent in Genomically Defined AML and MDS Patients
11/21/2017 BW Syros to Present at 29th Annual Piper Jaffray Healthcare Conference
11/08/2017 BW Syros Reports Third Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy